[What is the current treatment of patients with essential thrombocytopenia and other myeloproliferations accompanied with thrombocythemia [corrected] and what can be the predictive sign of the risk of thrombosis in such patients--a report from the registry of patients treated by Thromboreductine]. / Jak lécíme nemocné s esenciální trombocytemií a dalsími myeloproliferacemi provázenými trombocytemií a co muze být prediktivní známkou rizika trombózy u techto nemocných--zpráva z registru pacientu lécených Thromboreductinem.
Vnitr Lek
; 54(7-8): 775-82, 2008.
Article
em Cs
| MEDLINE
| ID: mdl-18780577
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Quinazolinas
/
Trombocitopenia
/
Trombose
/
Inibidores da Agregação Plaquetária
/
Fibrinolíticos
/
Trombocitemia Essencial
/
Transtornos Mieloproliferativos
Idioma:
Cs
Ano de publicação:
2008
Tipo de documento:
Article